Perceptic offers an infrastructure- and model-agnostic AI platform that ties together disparate AI tools and pharmaceutical data to support drug discovery, indication selection, and clinical trial design. The system harmonizes public, proprietary, and purchased external datasets and uses tuned AI agents to extract insights while providing traceability to sources to avoid hallucinations. The company highlights a 50-fold increase in clinical data extractions from its data foundation and says its software is already used by multiple top-tier pharma customers, including CSL. Perceptic was founded by former Palantir life sciences engineers and has grown to about 20 employees with most engineering based in London. The company reports it has moved into paid production deployments and plans to scale engineering and customer growth, including expanding its U.S. presence.

Total raised

$12M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2026